Skip to content

Cumberland Pharmaceuticals CPIX Short- and long-term operating lease liabilities

Short- and long-term operating lease liabilities at other companies

Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$125K-495%
Rumble, Inc. logo
Rumble, Inc.RUM
-$337.78K-40.4%
SelectQuote logo
SelectQuoteSLQT
-$1.12M+13.3%
Mission Produce, Inc. logo
Mission Produce, Inc.AVO
-$2.8M-3.7%
The Baldwin Insurance Group, Inc. logo
The Baldwin Insurance Group, Inc.BWIN
-$4.74M-16.2%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
-$1.68M-6.3%

Other financials

Income statement

See full
Revenue$9.1M-22.0%
Gross profit$7.2M-30.0%
Operating income-$3.1M-342%
Net income-$3.3M-362%
EPS (diluted)-$0.22-375%

Balance sheet

See full
Cash & equivalents$11.0M-27.1%
Total debt$4.8M-7.1%
Total equity$21.6M-24.5%
Total assets$71.0M+1.5%

Cash flow

See full
Operating cash flow$387.0K-90.1%
CapEx--100%
Free cash flow$387.0K-89.9%

Valuation

See full
Market cap$97.09M+138%
Enterprise value$90.91M+207%
P/S2.3×+1.3×

Profitability

See full
Gross margin82.9%-1.4pp
Operating margin-17.2%-125pp
Net margin-17.6%-103pp
FCF margin3.3%

Returns & leverage

See full
Return on equity-29.4%-86.3pp
Debt / equity0.2×0.0×
Current ratio-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's short- and long-term operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cumberland Pharmaceuticals's short- and long-term operating lease liabilities?
Cumberland Pharmaceuticals (CPIX) reported short- and long-term operating lease liabilities of -$225.35K in Q1 2026.
How has Cumberland Pharmaceuticals's short- and long-term operating lease liabilities changed year-over-year?
Cumberland Pharmaceuticals's short- and long-term operating lease liabilities decreased by 2.7% year-over-year, from -$219.49K to -$225.35K.